Paylocity Announces Second Quarter Fiscal Year 2017

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
Paylocity Announces Second Quarter Fiscal Year 2017 Financial Results
  • Q2 2017 Total Revenue of $68.7 million, up 24% year-over-year
  • Q2 2017 Recurring Revenue of $66.1 million, up 26% year-over-year

ARLINGTON HEIGHTS, Ill., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY ), a cloud-based provider of payroll and human capital management software solutions, today announced financial results for the second quarter of fiscal year 2017, which ended December 31, 2016.

“I was pleased with our second quarter in terms of both top and bottom line performance given the challenge in comparing to the record-setting revenue growth in the second quarter of last fiscal year.” said Steve Beauchamp, President and Chief Executive Officer of Paylocity. “We continue to realize value from our product investments, as our newly released Recruiting product is off to a good start and we just launched our newest module, Expense Management. We continue to focus on investments in both our products and our people and were recently recognized as the #14 Best Places to Work in the Glassdoor Employees’ Choice Award.”

Second Quarter Fiscal 2017 Financial Highlights

Revenue:

  • Total revenue was $68.7 million, an increase of 24% from the second quarter of fiscal year 2016. 
  • Total recurring revenue was $66.1 million, representing 96% of total revenue and an increase of 26% from the second quarter of fiscal year 2016. 

Operating Income (Loss):

  • GAAP operating loss was ($1.6) million, compared to an operating loss of ($1.3) million in the second quarter of fiscal year 2016.
  • Non-GAAP operating income was $5.4 million, compared to non-GAAP operating income of $4.0 million in the second quarter of fiscal year 2016.

Net Income (Loss):

  • GAAP net loss was ($1.7) million. This compares to a net loss of ($1.2) million for the second quarter of fiscal year 2016. Net loss per share was ($0.03) for the second quarter of fiscal year 2017 based on 51.4 million basic and diluted weighted average common shares outstanding. Net loss per share was ($0.02) for the second quarter of fiscal year 2016, based on 50.9 million basic and diluted weighted average common shares outstanding.
  • Non-GAAP net income was $5.4 million. This compares to non-GAAP net income of $4.1 million for the second quarter of fiscal year 2016. Non-GAAP net income per share was $0.10 for the second quarter of fiscal year 2017, based on 53.9 million pro forma diluted weighted average common shares outstanding. Non-GAAP net income per share was $0.08 for the second quarter of fiscal year 2016, based on 53.7 million pro forma diluted weighted average common shares outstanding. 

Adjusted EBITDA:

  • Adjusted EBITDA, a non-GAAP measure, was $9.9 million compared to Adjusted EBITDA of $7.2 million in the second quarter of fiscal year 2016.

Balance Sheet and Cash Flow:

  • Cash and cash equivalents totaled $82.3 million at the end of the quarter.   
  • Cash flow from operations for the second quarter of fiscal year 2017 was $13.5 million compared to $7.8 million for the second quarter of fiscal year 2016.

A reconciliation of GAAP to non-GAAP financial measures has been provided in this press release, including the accompanying tables.  An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures.”

Business Outlook

Based on information available as of February 2, 2017, Paylocity is issuing guidance for the third quarter and full fiscal year 2017 as indicated below.

Third Quarter 2017 :

  • Total revenue is expected to be in the range of $87.5 million to $88.5 million.
  • Adjusted EBITDA is expected to be in the range of $17.0 million to $18.0 million.
  • Non-GAAP net income is expected to be in the range of $12.0 million to $13.0 million, or $0.22 to $0.24 per share, based on approximately 54 million diluted weighted average common shares outstanding.

Fiscal Year 2017 :

  • Total revenue is expected to be in the range of $296.0 million to $298.0 million.
  • Adjusted EBITDA is expected to be in the range of $42.0 million to $43.0 million.
  • Non-GAAP net income is expected to be in the range of $22.5 million to $23.5 million, or $0.41 to $0.43 per share, based on approximately 55 million diluted weighted average common shares outstanding.

We are unable to reconcile these forward-looking non-GAAP financial measures to their directly comparable GAAP financial measures because the information which is needed to complete a reconciliation is unavailable at this time without unreasonable effort.

Conference Call Details

Paylocity will host a conference call to discuss its second quarter fiscal year 2017 results at 4:00 p.m. Central Time today (5:00 Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the company's Investor Relations Web site at http://www.paylocity.com . Participants who choose to call in to the conference call can do so by dialing (855) 226-3021 or (315) 625-6892, passcode 39058974. A replay of the call will be available and archived via webcast at www.paylocity.com .

About Paylocity

Paylocity is a provider of cloud-based payroll and human capital management, or HCM, software solutions for medium-sized organizations. Paylocity’s comprehensive and easy-to-use solutions enable its clients to manage their workforces more effectively.  Paylocity’s solutions help drive strategic human capital decision-making and improve employee engagement by enhancing the human resource, payroll and finance capabilities of its clients. For more information, visit www.paylocity.com .

Non-GAAP Financial Measures The company uses certain non-GAAP financial measures in this release, including Adjusted EBITDA, adjusted gross profit, adjusted recurring gross profit, non-GAAP operating income (loss), non-GAAP net income (loss), non-GAAP net income (loss) per share, non-GAAP sales and marketing, non-GAAP total research and development and non-GAAP general and administrative. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. We define Adjusted EBITDA as net income (loss) before interest expense, income tax expense, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises. Adjusted gross profit and adjusted recurring gross profit are adjusted to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises and amortization of capitalized internal-use software costs. Non-GAAP operating income (loss) is adjusted to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises and the amortization of acquired intangibles. Non-GAAP sales and marketing expense is adjusted to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises. Non-GAAP general and administrative expense is adjusted to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises and the amortization of acquired intangibles. Non-GAAP net income (loss) and non-GAAP net income (loss) per share are adjusted to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises and the amortization of acquired intangibles. Pro forma diluted weighted average number of common shares are adjusted for the weighted average effect of potentially diluted shares. Non-GAAP total research and development is adjusted for capitalized internal-use software costs and to eliminate stock-based compensation expense and employer payroll taxes related to stock releases and option exercises. Please note that other companies may define their non-GAAP financial measures differently than we do. Management presents certain non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, the inclusion of the non-GAAP financial measures should provide consistency in the company’s financial reporting. Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release.

Safe Harbor/forward looking statements This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included herein regarding Paylocity’s future operations, future financial position and performance, future revenues, projected costs, prospects, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “will,” “would,” “seek” and similar expressions (or the negative of these terms) are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among other things, statements about management's estimates regarding future revenues and financial performance and other statements about management’s beliefs, intentions or goals.  Paylocity may not actually achieve the expectations disclosed in the forward-looking statements, and you should not place undue reliance on Paylocity’s forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to differ materially from the expectations disclosed in the forward-looking statements, including, but not limited to, risks related to regulatory, legislative and judicial uncertainty in Paylocity’s markets, including the potential repeal or replacement of the Affordable Care Act; Paylocity’s ability to retain existing clients and to attract new clients to enter into subscriptions for its services; Paylocity’s ability to sell new products and retain subscriptions for its existing products, such as ACA Enhanced, to its new and existing clients; the challenges associated with a growing company’s ability to effectively service clients in a dynamic and competitive market; challenges associated with expanding and evolving a sales organization to effectively address new geographies and products and services; Paylocity’s reliance on and ability to expand its referral network of third parties; difficulties associated with accurately forecasting revenue and appropriately planning expenses; challenges with managing growth effectively; difficulties in forecasting Paylocity’s tax position, including but not limited to the assessment of the need for a valuation allowance against its deferred tax position; continued acceptance of SaaS as an effective method for delivery of payroll and HCM solutions; Paylocity’s ability to protect and defend its intellectual property; the risk that Paylocity’s security measures are compromised or the unauthorized access to customer data; unexpected events in the market for Paylocity’s solutions; changes in the competitive environment in Paylocity’s industry and the markets in which it operates; adverse changes in general economic or market conditions; changes in the employment rates of Paylocity’s clients and the resultant impact on revenue; and other risks and potential factors that could affect Paylocity’s business and financial results identified in Paylocity’s filings with the Securities and Exchange Commission (the “SEC”), including its 10-K filed with the SEC on August 12, 2016.  Additional information will also be set forth in Paylocity’s future quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings that Paylocity makes with the SEC.  These forward-looking statements represent Paylocity’s expectations as of the date of this press release. Subsequent events may cause these expectations to change, and Paylocity disclaims any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise.

PAYLOCITY HOLDING CORPORATION
 Unaudited Consolidated Balance Sheets
 (in thousands, except per share data)
 
    June 30,   December 31,
Assets     2016       2016
Current assets:        
Cash and cash equivalents   $ 86,496         $ 82,257  
Accounts receivable, net     1,681        2,067  
Prepaid expenses and other     7,409        11,291  
         
Total current assets before funds held for clients     95,586        95,615  
Funds held for clients     1,239,622        1,092,471  
         
Total current assets     1,335,208        1,188,086  
Long-term prepaid expenses     845        618  
Capitalized internal-use software, net     11,427        14,944  
Property and equipment, net     26,787        33,633  
Intangible assets, net     10,419        9,657  
Goodwill     6,003        6,003  
         
Total assets   $ 1,390,689     $  1,252,941  
         
Liabilities and Stockholders’ Equity        
         
Current liabilities:        
         
Accounts payable   $ 1,621     $ 3,134  
Accrued expenses     24,979        22,096  
         
Total current liabilities before client fund obligations     26,600        25,230  
Client fund obligations     1,239,622        1,092,471  
         
Total current liabilities     1,266,222        1,117,701  
Deferred rent     4,646        9,548  
Deferred income tax liabilities, net     249        351  
         
Total liabilities   $ 1,271,117     $  1,127,600  
Stockholders’ equity:        
Preferred stock, $0.001 par value, 5,000 authorized, no shares issued and outstanding at June 30, 2016 and December 31, 2016   $     $  
Common stock, $0.001 par value, 155,000 shares authorized at June 30, 2016 and December 31, 2016; 51,132 shares issued and outstanding at June 30, 2016 and 51,430 shares issued and outstanding at December 31, 2016     51        51  
Additional paid-in capital     171,515        181,523  
Accumulated deficit     (51,994 )      (56,233 )
Total stockholders’ equity   $ 119,572     $  125,341  
Total liabilities and stockholders’ equity   $ 1,390,689     $  1,252,941  
PAYLOCITY HOLDING CORPORATION
Unaudited Consolidated Statements of Operations
 (in thousands, except per share data)
 
    Three months ended  December 31,   Six months ended  December 31,
      2015       2016       2015       2016  
Revenues:                
Recurring fees   $ 51,732     $ 65,347     $ 94,095     $ 127,267  
Interest income on funds held for clients     615       731       1,143       1,448  
Total recurring revenues     52,347       66,078       95,238       128,715  
Implementation services and other     2,837       2,576       5,054       4,961  
Total revenues     55,184       68,654       100,292       133,676  
Cost of revenues:                
Recurring revenues     16,125       20,716       29,282       39,819  
Implementation services and other     7,975       9,667       15,013       18,923  
Total cost of revenues     24,100       30,383       44,295       58,742  
Gross profit     31,084       38,271       55,997       74,934  
Operating expenses:                
Sales and marketing     14,340       17,735       26,790       35,746  
Research and development     6,799       7,222       12,228       14,523  
General and administrative     11,239       14,957       21,690       28,815  
Total operating expenses     32,378       39,914       60,708       79,084  
Operating loss     (1,294 )     (1,643 )     (4,711 )     (4,150 )
Other income     214       4       297       43  
Loss before income taxes     (1,080 )     (1,639 )     (4,414 )     (4,107 )
Income tax expense     85       32       186       132  
Net loss   $ (1,165 )   $ (1,671 )   $ (4,600 )   $ (4,239 )
Net loss per share:                
Basic   $   (0.02 )   $   (0.03 )   $ (0.09 )   $ (0.08 )
Diluted $   (0.02 ) $ (0.03 )   $ (0.09 )   $ (0.08 )
Weighted-average shares used in computing net loss per share:                
Basic     50,890       51,384       50,817       51,308  
Diluted   50,890     51,384       50,817       51,308  

Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises are included in the above line items:

  Three months ended December 31,   Six months ended December 31,
  2015     2016     2015     2016  
Cost of revenue - recurring $ 461   $ 600   $ 858   $ 1,205 
Cost of revenue -  implementation services and other    311     373     602     721 
Sales and marketing    1,228     1,697     2,155     3,294 
Research and development    823     877     1,450     1,777 
General and administrative    2,057     3,127     3,721     5,848 
Total $ 4,880   $ 6,674   $ 8,786   $ 12,845 
PAYLOCITY HOLDING CORPORATION
Unaudited Consolidated Statements of Cash Flows
 (in thousands)
 
    Six Months Ended December 31,
      2015       2016  
Cash flows from operating activities:        
         
Net loss   $ (4,600 )   $ (4,239 )
Adjustments to reconcile net loss to net cash provided by operating activities:        
Stock-based compensation expense     8,492       12,448  
Depreciation and amortization expense     6,155       9,103  
Deferred income tax expense     151       102  
Provision for doubtful accounts     75       60  
Loss on disposal of equipment     168       97  
Changes in operating assets and liabilities:        
Accounts receivable     (428 )     (446 )
Prepaid expenses     (891 )     845  
Trade accounts payable     653       46  
Accrued expenses     1,039       (2,626 )
Net cash provided by operating activities     10,814       15,390  
         
Cash flows from investing activities:        
Capitalized internal-use software costs     (3,775 )     (6,279 )
Purchases of property and equipment     (6,865 )     (10,038 )
Payments for acquisitions     (183 )      
Net change in funds held for clients     (291,918 )     147,151  
Net cash provided by (used in) investing activities     (302,741 )     130,834  
         
Cash flows from financing activities:        
Net change in client funds obligation     291,918       (147,151 )
Proceeds from exercise of stock options     137        
Proceeds from employee stock purchase plan     1,403       1,823  
Taxes paid related to net share settlement of equity awards     (3,765 )     (5,135 )
Net cash provided by (used in) financing activities     289,693       (150,463 )
Net Change in Cash and Cash Equivalents     (2,234 )     (4,239 )
Cash and Cash Equivalents—Beginning of Period     81,258       86,496  
Cash and Cash Equivalents—End of Period   $ 79,024     $ 82,257  
Supplemental Disclosure of Non-Cash Investing and Financing Activities        
Build-out allowance received from landlord   $ 55     $   —  
Unpaid follow-on offering costs included in accrued expenses   $ 152     $   —  
Purchase of property and equipment, accrued but not paid   $ 1,531     $   2,172  
Supplemental Disclosure of Cash Flow Information        
Cash paid for income taxes, net of refunds   $ 22     $   26  
Paylocity Holding Corporation
Reconciliation of GAAP to non-GAAP Financial Measures
(In thousands except per share data)
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation from gross profit to adjusted gross profit:          
Gross profit $   31,084   $   38,271     $   55,997   $   74,934  
Amortization of capitalized internal-use software costs     1,423       1,950         2,365       3,634  
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     772       973         1,460       1,926  
Adjusted gross profit $   33,279   $   41,194     $   59,822   $   80,494  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation from total recurring revenues to adjusted recurring gross profit:          
Total recurring revenues $   52,347   $   66,078     $   95,238   $   128,715  
Cost of recurring revenues     16,125       20,716         29,282       39,819  
Recurring gross profit     36,222       45,362         65,956       88,896  
Amortization of capitalized internal-use software costs     1,423       1,950         2,365       3,634  
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     461       600         858       1,205  
Adjusted recurring gross profit $   38,106   $   47,912     $   69,179   $   93,735  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation from operating loss to non-GAAP operating income:          
Operating loss $   (1,294 ) $   (1,643 )   $   (4,711 ) $   (4,150 )
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     4,880       6,674         8,786       12,845  
Amortization of acquired intangibles     381       381         761       762  
Non-GAAP operating income $   3,967   $   5,412     $   4,836   $   9,457  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation from net loss to non-GAAP net income:          
Net loss $   (1,165 ) $   (1,671 )   $   (4,600 ) $   (4,239 )
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     4,880       6,674         8,786       12,845  
Amortization of acquired intangibles     381       381         761       762  
Non-GAAP net income  $   4,096   $   5,384     $   4,947   $   9,368  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation from diluted weighted-average number of common shares as reported to pro forma diluted weighted-average number of common shares          
Diluted weighted-average number of common shares, as reported     50,890       51,384         50,817       51,308  
Weighted-average effect of potentially dilutive shares     2,830       2,534         2,763       2,689  
Pro forma diluted weighted-average number of common shares     53,720       53,918         53,580       53,997  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Calculation of non-GAAP net income per share:          
Non-GAAP net income  $   4,096   $   5,384     $   4,947   $   9,368  
Pro forma diluted weighted-average number of common shares     53,720       53,918         53,580       53,997  
Non-GAAP net income per share $   0.08   $   0.10     $   0.09   $   0.17  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation from net loss to Adjusted EBITDA:          
Net loss $   (1,165 ) $   (1,671 )   $   (4,600 ) $   (4,239 )
Interest expense     -        -          -        -   
Income tax expense      85       32         186       132  
Depreciation and amortization     3,436       4,835         6,155       9,103  
EBITDA     2,356       3,196         1,741       4,996  
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     4,880       6,674         8,786       12,845  
Adjusted EBITDA $   7,236   $   9,870     $   10,527   $   17,841  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation of non-GAAP Sales and Marketing:          
Sales and Marketing  $   14,340   $   17,735     $   26,790   $   35,746  
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     1,228       1,697         2,155       3,294  
Non-GAAP Sales and Marketing $   13,112   $   16,038     $   24,635   $   32,452  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation of non-GAAP Total Research and Development:          
Research and Development  $   6,799   $   7,222     $   12,228   $   14,523  
Capitalized internal-use software costs     1,732       3,392         3,775       6,279  
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     823       877         1,450       1,777  
Non-GAAP Total Research and Development $   7,708   $   9,737     $   14,553   $   19,025  
           
  Three months Ended December 31,   Six months Ended December 31,
    2015     2016       2015     2016  
Reconciliation of non-GAAP General and Administrative:          
General and Administrative $   11,239   $   14,957     $   21,690   $   28,815  
Stock-based compensation expense and employer payroll taxes related to stock releases and option exercises     2,057       3,127         3,721       5,848  
Amortization of acquired intangibles     381       381         761       762  
Non-GAAP General and Administrative $   8,801   $   11,449     $   17,208   $   22,205  
           

 

CONTACT: Annemarie Pozo investors@paylocity.com 224.318.3900 www.paylocity.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

SAP Launches Sovereign Cloud Solution in Canada for Businesses

Updated Category News Views 365

SAP Enhances Data Security with New Cloud Solutions SAP SE shares are experiencing a positive trend in premarket trading. Recently, SAP Canada introduced its innovative SAP Sovereign Cloud capabilities, which are designed to address the increasing demand from organizations for data sovereignty, robust security, and regulatory compliance. This pioneering solution enables...

Continue Reading
Corbus Pharma's Stock Drops 60%: Analysts Recommend Buying Now

Updated Category News Views 92

Corbus Pharmaceuticals Sees Significant Stock Drop Amid Market Responses Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has recently faced a dramatic decline in its stock, plummeting by an alarming 60%. However, analysts are encouraging investors to view this as a potential buying opportunity. Firms like H.C. Wainwright and Oppenheimer have reaffirmed their buy...

Continue Reading
Manatt Welcomes New Partner with Extensive Investment Expertise

Updated Category News Views 139

Manatt's Strategic Growth in Corporate Practice Manatt, Phelps & Phillips, LLP is making waves in the corporate legal landscape with its recent addition of Peter Tsirigotis, a seasoned investment funds partner. This move reflects the firm's commitment to expanding its financial services and corporate capabilities. Based in Washington, D.C., Tsirigotis brings a wealth of...

Continue Reading
Performance Share Units Vesting: ISS A/S Updates Details

Updated Category News Views 216

Performance Share Units Vesting Announcement ISS A/S is proud to announce the significant milestone concerning its long-term incentive program (LTIP). As part of this initiative, a number of Performance Share Units (PSUs) have recently vested, leading to the delivery of ISS shares to key personnel within the company. This process, which emphasizes the company's commitment...

Continue Reading
Omnicom Boosts Dividend: New Shareholder Benefit Unveiled

Updated Category News Views 196

Omnicom Boosts Dividend for Shareholders Omnicom, a renowned leader in marketing and sales, has officially announced an increase in its quarterly dividend to $0.80 per share. This enhancement reflects a significant increase in the company's commitment to its shareholders, offering both immediate rewards and a long-term strategy for growth. Dividend Increase Overview The...

Continue Reading